Also trades as: ABBOTINDIA.NS (NSE) · $vol 3M
ABBOTINDIA.BO BSE
Abbott India Limited
1W: -0.3%
1M: +2.4%
3M: +3.8%
YTD: -1.8%
1Y: -18.7%
3Y: +15.7%
5Y: +57.6%
₹26,780.00 ($278.09)
-369.40 (-1.36%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
No convergence signal
Key Statistics
Market Cap₹569.6B ($5.9B)
52W Range25140.5-35921.55
Volume968
Avg Volume648
Beta-0.00
Dividend₹656.00
Analyst Ratings
No analyst coverage
Company Info
CEOKartik Rajendran
Employees3,749
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2000-01-03
Websiteabbott.co.in
Godrej BKC
Mumbai, MA 400 051
IN
Mumbai, MA 400 051
IN
91 22 5046 1000
About Abbott India Limited
Abbott India Limited is an Indian pharmaceutical enterprise primarily engaged in the development and distribution of a diverse range of medicinal products. Its extensive portfolio addresses critical therapeutic areas such as women's health, gastroenterology, metabolic disorders, central nervous system conditions, and vaccines. The company also offers multi-specialty solutions for insomnia, vitamin D deficiency, pre-term labor, and pain management, alongside anti-infectives, cardio-diabetic treatments, hormones, respiratory care, hepatic products, and consumer health items. Founded in 1910, the company's main office is located in Mumbai, India, and it operates as a subsidiary of Abbott Capital India Limited.
Latest News
No recent news
Recent Insider Trades
No insider trades found